(Q26471520)

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Daily versus as-needed corticosteroids for mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Prevention of viral induced asthma attacks using inhaled budesonide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Comparison of single 2000-microg dose treatment vs. sequential repeated-dose 500-microg treatments with nebulized budesonide in acute asthma exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Inhaled flunisolide for acute severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Inhaled budesonide in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Budesonide for chronic asthma in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Preemptive use of high-dose fluticasone for virus-induced wheezing in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Estimation of a common effect parameter from sparse follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Asthma exacerbations . 1: epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

An international observational prospective study to determine the cost of asthma exacerbations (COAX).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Adult Asthma Consensus Guidelines update 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Corticosteroids in chronic obstructive pulmonary disease. Clinical benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Oral prednisolone for preschool children with acute virus-induced wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Early emergency department treatment of acute asthma with systemic corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Statistics in medicine--reporting of subgroup analyses in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

A prospective multicenter study of patient factors associated with hospital admission from the emergency department among children with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Glucocorticoids in acute asthma. A critical controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Early corticosteroid use in acute exacerbations of chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Meta-analysis of correlation coefficients: A Monte Carlo comparison of fixed- and random-effects methods

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021

The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007524.PUB4

7 January 2021